New data presented at the 2007 RSNA meeting may help ease fears that use of preoperative breast MRI will hike mastectomy rates and cause delays in time to surgery.
New data presented at the 2007 RSNA meeting may help ease fears that use of preoperative breast MRI will hike mastectomy rates and cause delays in time to surgery.
Greater utilization of dynamic contrast-enhanced MRI at the University of California, San Diego over a six-year period helped improve surgery planning for tough cases without hiking mastectomy rates, according to a retrospective study by Dr. Christopher Comstock and colleagues.
The UCSD study evaluated the effects of preoperative MRI on surgery in terms of delays and margins on patients with biopsy-proven breast cancer who underwent surgery at UCSD from 2000 to 2006. In the first two years of the study period, only one patient had preoperative MRI, but by the latter part of 2003, 40% to 50% of surgical patients were undergoing the imaging study.
Critics say preoperative MRI can increase mastectomy rates and cause delays in surgery due to clinically insignificant disease detected by MRI. They are less likely to cite lumpectomy's positive margin rates, which range from 30% to 40% nationwide and result in multiple surgeries to obtain clear margins. At UCSD, the lumpectomy negative margin rate was higher for those who had preoperative MRI (80%) versus those who did not (75%).
"This may not seem like a big difference, but those who underwent preoperative MRI had larger or more complicated cancers or parenchymal patterns," Comstock said.
Furthermore, lumpectomy negative margin rates reached 90% by 2006 and there was no significant difference in the time to surgery. Despite increasing utilization of preoperative MRI, mastectomy rates remained stable throughout most of the study period, thanks to good communication between specialists and effective counseling of patients, Comstock reported.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.